
The global Implantable Continuous Glucose Monitoring System market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Implantable Continuous Glucose Monitoring System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Implantable Continuous Glucose Monitoring System market size and forecasts, in consumption value ($ Million), 2020-2031
Global Implantable Continuous Glucose Monitoring System market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Implantable Continuous Glucose Monitoring System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Implantable Continuous Glucose Monitoring System market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Implantable Continuous Glucose Monitoring System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Implantable Continuous Glucose Monitoring System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlySens, Medtronic, DexCom, Senseonics Holdings, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Implantable Continuous Glucose Monitoring System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sensor
Transmitter
Receiver
Market segment by Application
Children
Adults
Market segment by players, this report covers
GlySens
Medtronic
DexCom
Senseonics Holdings
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Implantable Continuous Glucose Monitoring System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Implantable Continuous Glucose Monitoring System, with revenue, gross margin, and global market share of Implantable Continuous Glucose Monitoring System from 2020 to 2025.
Chapter 3, the Implantable Continuous Glucose Monitoring System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Implantable Continuous Glucose Monitoring System market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Implantable Continuous Glucose Monitoring System.
Chapter 13, to describe Implantable Continuous Glucose Monitoring System research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Implantable Continuous Glucose Monitoring System by Type
1.3.1 Overview: Global Implantable Continuous Glucose Monitoring System Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Implantable Continuous Glucose Monitoring System Consumption Value Market Share by Type in 2024
1.3.3 Sensor
1.3.4 Transmitter
1.3.5 Receiver
1.4 Global Implantable Continuous Glucose Monitoring System Market by Application
1.4.1 Overview: Global Implantable Continuous Glucose Monitoring System Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Children
1.4.3 Adults
1.5 Global Implantable Continuous Glucose Monitoring System Market Size & Forecast
1.6 Global Implantable Continuous Glucose Monitoring System Market Size and Forecast by Region
1.6.1 Global Implantable Continuous Glucose Monitoring System Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Implantable Continuous Glucose Monitoring System Market Size by Region, (2020-2031)
1.6.3 North America Implantable Continuous Glucose Monitoring System Market Size and Prospect (2020-2031)
1.6.4 Europe Implantable Continuous Glucose Monitoring System Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Implantable Continuous Glucose Monitoring System Market Size and Prospect (2020-2031)
1.6.6 South America Implantable Continuous Glucose Monitoring System Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Implantable Continuous Glucose Monitoring System Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 GlySens
2.1.1 GlySens Details
2.1.2 GlySens Major Business
2.1.3 GlySens Implantable Continuous Glucose Monitoring System Product and Solutions
2.1.4 GlySens Implantable Continuous Glucose Monitoring System Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 GlySens Recent Developments and Future Plans
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Implantable Continuous Glucose Monitoring System Product and Solutions
2.2.4 Medtronic Implantable Continuous Glucose Monitoring System Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Medtronic Recent Developments and Future Plans
2.3 DexCom
2.3.1 DexCom Details
2.3.2 DexCom Major Business
2.3.3 DexCom Implantable Continuous Glucose Monitoring System Product and Solutions
2.3.4 DexCom Implantable Continuous Glucose Monitoring System Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 DexCom Recent Developments and Future Plans
2.4 Senseonics Holdings
2.4.1 Senseonics Holdings Details
2.4.2 Senseonics Holdings Major Business
2.4.3 Senseonics Holdings Implantable Continuous Glucose Monitoring System Product and Solutions
2.4.4 Senseonics Holdings Implantable Continuous Glucose Monitoring System Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Senseonics Holdings Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Implantable Continuous Glucose Monitoring System Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Implantable Continuous Glucose Monitoring System by Company Revenue
3.2.2 Top 3 Implantable Continuous Glucose Monitoring System Players Market Share in 2024
3.2.3 Top 6 Implantable Continuous Glucose Monitoring System Players Market Share in 2024
3.3 Implantable Continuous Glucose Monitoring System Market: Overall Company Footprint Analysis
3.3.1 Implantable Continuous Glucose Monitoring System Market: Region Footprint
3.3.2 Implantable Continuous Glucose Monitoring System Market: Company Product Type Footprint
3.3.3 Implantable Continuous Glucose Monitoring System Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Implantable Continuous Glucose Monitoring System Consumption Value and Market Share by Type (2020-2025)
4.2 Global Implantable Continuous Glucose Monitoring System Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Implantable Continuous Glucose Monitoring System Consumption Value Market Share by Application (2020-2025)
5.2 Global Implantable Continuous Glucose Monitoring System Market Forecast by Application (2026-2031)
6 North America
6.1 North America Implantable Continuous Glucose Monitoring System Consumption Value by Type (2020-2031)
6.2 North America Implantable Continuous Glucose Monitoring System Market Size by Application (2020-2031)
6.3 North America Implantable Continuous Glucose Monitoring System Market Size by Country
6.3.1 North America Implantable Continuous Glucose Monitoring System Consumption Value by Country (2020-2031)
6.3.2 United States Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
6.3.3 Canada Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
6.3.4 Mexico Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Implantable Continuous Glucose Monitoring System Consumption Value by Type (2020-2031)
7.2 Europe Implantable Continuous Glucose Monitoring System Consumption Value by Application (2020-2031)
7.3 Europe Implantable Continuous Glucose Monitoring System Market Size by Country
7.3.1 Europe Implantable Continuous Glucose Monitoring System Consumption Value by Country (2020-2031)
7.3.2 Germany Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
7.3.3 France Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
7.3.5 Russia Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
7.3.6 Italy Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Implantable Continuous Glucose Monitoring System Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Implantable Continuous Glucose Monitoring System Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Implantable Continuous Glucose Monitoring System Market Size by Region
8.3.1 Asia-Pacific Implantable Continuous Glucose Monitoring System Consumption Value by Region (2020-2031)
8.3.2 China Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
8.3.3 Japan Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
8.3.4 South Korea Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
8.3.5 India Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
8.3.7 Australia Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
9 South America
9.1 South America Implantable Continuous Glucose Monitoring System Consumption Value by Type (2020-2031)
9.2 South America Implantable Continuous Glucose Monitoring System Consumption Value by Application (2020-2031)
9.3 South America Implantable Continuous Glucose Monitoring System Market Size by Country
9.3.1 South America Implantable Continuous Glucose Monitoring System Consumption Value by Country (2020-2031)
9.3.2 Brazil Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
9.3.3 Argentina Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Implantable Continuous Glucose Monitoring System Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Implantable Continuous Glucose Monitoring System Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Implantable Continuous Glucose Monitoring System Market Size by Country
10.3.1 Middle East & Africa Implantable Continuous Glucose Monitoring System Consumption Value by Country (2020-2031)
10.3.2 Turkey Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
10.3.4 UAE Implantable Continuous Glucose Monitoring System Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Implantable Continuous Glucose Monitoring System Market Drivers
11.2 Implantable Continuous Glucose Monitoring System Market Restraints
11.3 Implantable Continuous Glucose Monitoring System Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Implantable Continuous Glucose Monitoring System Industry Chain
12.2 Implantable Continuous Glucose Monitoring System Upstream Analysis
12.3 Implantable Continuous Glucose Monitoring System Midstream Analysis
12.4 Implantable Continuous Glucose Monitoring System Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
GlySens
Medtronic
DexCom
Senseonics Holdings
Ìý
Ìý
*If Applicable.
